Asian Pancreas Consortium: Building evidence through collaborative research for pancreatic care across Asia

This publication has 11 references indexed in Scilit:

• Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial
  The Lancet Gastroenterology & Hepatology, 2026
• Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies
  HPB, 2025
• Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial
  Cancer Cell, 2025
• Pancreatic cancer
  The Lancet, 2025
• Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement
  HPB, 2025
• Acute pancreatitis: pathogenesis and emerging therapies
  Journal of Pancreatology, 2024
• International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas
  Pancreatology, 2023
• Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial
  The Lancet, 2022
• New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS)
  Journal of Hepato-Biliary-Pancreatic Sciences, 2021
• Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer
  Annals of Surgery, 2018